Drug Shortage Report for AURO-IRBESARTAN
Report ID | 64667 |
Drug Identification Number | 02406128 |
Brand name | AURO-IRBESARTAN |
Common or Proper name | Irbesartan |
Company Name | AURO PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | IRBESARTAN |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2018-10-17 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-10-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-10-18 | French | Compare |
v1 | 2018-10-18 | English | Compare |
Showing 1 to 2 of 2